Bioidentical Hormone Replacement Therapy (BHRT)

What Is Bioidentical Hormone Replacement Therapy (BHRT)?

If you have noticed changes in how you feel as you get older, lower energy, disrupted sleep, mood shifts, or a fading sex drive, hormones are often part of the story. Bioidentical hormone replacement therapy (BHRT) uses hormones that are structurally identical to the ones your body makes. The most common are estradiol, progesterone, and testosterone, and in some protocols DHEA. “Bioidentical” refers to molecular structure, not to whether a product is compounded or commercially manufactured. Many FDA-approved products are themselves bioidentical, for example transdermal estradiol, oral or vaginal micronized progesterone, and standard testosterone preparations. The goal of BHRT is to restore hormone levels that have declined with age, surgical menopause, or an underlying endocrine condition, and to relieve the symptoms that come with that decline.

At ENNU Life in Louisville, BHRT is individualized, lab-guided medicine. Your dosing is based on measured blood levels, documented symptoms, and your full clinical picture, not on a fixed protocol.

Hormones, Mechanism, and How Levels Are Measured

Sex hormones act on receptors throughout your body: in the brain, bone, muscle, skin, cardiovascular system, and reproductive organs. As production falls, the downstream effects show up as the familiar symptoms of menopause, perimenopause, and age-related hypogonadism (low hormone production).

• Estradiol (E2) is the primary active estrogen. It is central to vasomotor symptoms (hot flashes, night sweats), vaginal and urinary tissue health, mood, sleep, and bone density.
• Progesterone balances estrogen’s effect on the uterine lining. In women with an intact uterus, a progestogen is required alongside estrogen to protect against endometrial overgrowth.
• Testosterone matters in both men and women for libido, energy, mood, lean muscle, and overall vitality.

Levels are typically assessed with a blood panel that may include estradiol, progesterone, total and free testosterone, sex hormone-binding globulin (SHBG), FSH, and LH, often alongside thyroid markers and a metabolic panel. Reference ranges are highly assay-dependent and vary by sex, age, menstrual-cycle phase, and whether a person is pre- or postmenopausal, so your results must be interpreted by a clinician against the specific laboratory’s reference intervals rather than a single universal number. Saliva testing is sometimes marketed for BHRT, but it is not considered a reliable basis for dosing in mainstream clinical practice.

Symptoms and Who Should Consider Evaluation

BHRT evaluation is appropriate for adults who have symptoms consistent with declining hormone levels. Common reasons to test include:

• Hot flashes, night sweats, and disrupted sleep
• Vaginal dryness, discomfort, or recurrent urinary symptoms (genitourinary syndrome of menopause)
• Mood changes, irritability, anxiety, or “brain fog”
• Low libido and changes in sexual function
• Fatigue, reduced stamina, or loss of muscle and strength
• Irregular cycles in perimenopause
• In men, symptoms of low testosterone such as low energy, low mood, reduced libido, and loss of lean mass

Decisions about therapy weigh symptom severity, timing relative to menopause, and your personal risk factors. Hormone therapy is generally most favorable when started in women under 60 or within roughly ten years of menopause onset. It is not right for everyone. A personal history of estrogen-sensitive breast cancer, unexplained vaginal bleeding, active liver disease, or a history of certain blood clots or cardiovascular events typically makes systemic hormone therapy inadvisable. These contraindications are why evaluation by a licensed clinician is essential before you start.

What Optimization Looks Like

Well-managed BHRT is not about pushing levels as high as possible. It is about restoring balance to relieve symptoms at the lowest effective dose. A typical optimization path includes:

• Baseline assessment: symptom history, medical and family history, and appropriate baseline labs.
• Individualized dosing: selecting the hormone, delivery route (transdermal, oral, injectable, or pellet), and dose suited to you. Transdermal estrogen, for example, is often preferred over oral when clotting risk is a consideration.
• Endometrial protection: a progestogen for any woman with a uterus receiving systemic estrogen.
• Follow-up and monitoring: rechecking symptoms and labs after you start, then periodically, and continuing age-appropriate screening such as mammograms and, in men on testosterone, hematocrit and PSA monitoring.
• Ongoing reassessment: adjusting or tapering therapy over time as your needs and risk profile change.

What patients most often report is relief of disruptive symptoms: better sleep, steadier mood, restored libido, and improved energy, within a framework that is monitored and adjusted over time.

Start With an Evaluation

Because hormone needs, risks, and assay reference ranges differ for every person, the right starting point is a thorough, lab-guided assessment.

Take the ENNU Life Health Assessment to begin your personalized hormone evaluation.

Educational only, not medical advice. This page does not establish a provider-patient relationship. Hormone reference ranges are assay-dependent, and BHRT carries risks and contraindications. Consult a licensed clinician before starting, changing, or stopping any therapy.